INNOVATE BIOPHARMACEUTICALS (INNT) Covered Calls

You can sell covered calls on INNOVATE BIOPHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INNT (prices last updated Thu 4:16 PM ET):

INNOVATE BIOPHARMACEUTICALS (INNT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.36 +0.32 4.90 5.40 713K - 0.1B
Covered Calls For INNOVATE BIOPHARMACEUTICALS (INNT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 5 0.35 5.05 -1.0% -9.9%
Nov 16 5 0.15 5.25 -4.8% -18.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase 2b clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase 1 clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease. In addition, the company holds global rights for INN-329, a formulation of secretin that is used to enhance visualization in magnetic resonance cholangiopancreatography procedures that is in Phase 3 clinical trial. Innovate Biopharmaceuticals, Inc. is based in Raleigh, North Carolina